Wednesday, March 4, 2015

Bristol-Myers Squibb Enters Drug Licensing Deal With Danish Biotechnology Firm by CHAD BRAY



By CHAD BRAY


Under the deal, Bavarian Nordic could receive as much as $975 million to license its advanced prostate cancer treatment, Prostvac.


Published: March 5, 2015 at 12:00AM


from NYT Business Day http://ift.tt/1B06TVv






from WordPress http://ift.tt/17PZpsL

via Hadi Aboukhater
Posted by at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)